Rosetta Genomics Ltd. eliminated the position of chief commercial officer from the company.
As a result, the company terminated Mark Willig from employment.
Discover more about S&P Global’s offerings
Rosetta Genomics eliminates chief commercial officer position
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Rosetta Genomics Ltd. eliminated the position of chief commercial officer from the company.
As a result, the company terminated Mark Willig from employment.